<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(4)</volume><submitter>Dooley AJ</submitter><pubmed_abstract>Virtual screening, a fast, computational approach to identify drug leads [Perola, E.; Xu, K.; Kollmeyer, T. M.; Kaufmann, S. H.; Prendergast, F. G. J. Med. Chem.2000, 43, 401; Miller, M. A. Nat. Rev. Drug Disc.2002, 1 220], is limited by a known challenge in crystallographically determining flexible regions of proteins. This approach has not been able to identify active inhibitors of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) using solely the crystal structures of a SARS-CoV cysteine proteinase with a flexible loop in the active site [Yang, H. T.; Yang, M. J.; Ding, Y.; Liu, Y. W.; Lou, Z. Y. Proc. Natl. Acad. Sci. U.S.A.2003, 100, 13190; Jenwitheesuk, E.; Samudrala, R. Bioorg. Med. Chem. Lett.2003, 13, 3989; Rajnarayanan, R. V.; Dakshanamurthy, S.; Pattabirama</pubmed_abstract><journal>Bioorganic &amp; medicinal chemistry letters</journal><pagination>830-3</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7119130</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>From genome to drug lead: identification of a small-molecule inhibitor of the SARS virus.</pubmed_title><pmcid>PMC7119130</pmcid><pubmed_authors>Shindo N</pubmed_authors><pubmed_authors>Park JG</pubmed_authors><pubmed_authors>Dooley AJ</pubmed_authors><pubmed_authors>Pang YP</pubmed_authors><pubmed_authors>Taggart B</pubmed_authors></additional><is_claimable>false</is_claimable><name>From genome to drug lead: identification of a small-molecule inhibitor of the SARS virus.</name><description>Virtual screening, a fast, computational approach to identify drug leads [Perola, E.; Xu, K.; Kollmeyer, T. M.; Kaufmann, S. H.; Prendergast, F. G. J. Med. Chem.2000, 43, 401; Miller, M. A. Nat. Rev. Drug Disc.2002, 1 220], is limited by a known challenge in crystallographically determining flexible regions of proteins. This approach has not been able to identify active inhibitors of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) using solely the crystal structures of a SARS-CoV cysteine proteinase with a flexible loop in the active site [Yang, H. T.; Yang, M. J.; Ding, Y.; Liu, Y. W.; Lou, Z. Y. Proc. Natl. Acad. Sci. U.S.A.2003, 100, 13190; Jenwitheesuk, E.; Samudrala, R. Bioorg. Med. Chem. Lett.2003, 13, 3989; Rajnarayanan, R. V.; Dakshanamurthy, S.; Pattabirama</description><dates><release>2006-01-01T00:00:00Z</release><publication>2006 Feb</publication><modification>2026-04-28T22:00:09.141Z</modification><creation>2020-05-22T15:47:33Z</creation></dates><accession>S-EPMC7119130</accession><cross_references><pubmed>16325400</pubmed><doi>10.1016/j.bmcl.2005.11.018</doi></cross_references></HashMap>